Market Size of Asia-Pacific Cardiac Monitoring Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
Market Size (2024) | USD 4.65 Billion |
Market Size (2029) | USD 6.16 Billion |
CAGR (2024 - 2029) | 5.77 % |
Major Players*Disclaimer: Major Players sorted in no particular order |
Asia-Pacific Cardiac Monitoring Market Analysis
The Asia-Pacific Cardiac Monitoring Market size is estimated at USD 4.65 billion in 2024, and is expected to reach USD 6.16 billion by 2029, growing at a CAGR of 5.77% during the forecast period (2024-2029).
Cardiac monitoring devices are used to monitor and diagnose various abnormalities or disorders of the heart. The cardiac monitoring market is driven by rising burden of cardiovascular diseases, a growing ageing population who are very susceptible to coronary heart diseases, technological developments in cardiac monitoring devices that minimise the chances of infection, and improved efficiency of devices. Smoking is one of the major underlying causes of lung cancer and cardiac diseases. According to World Health Organisation (WHO), smoking causes around 1 million cardiovascular deaths in Asia-Pacific region each year. More than 1 in 5 cardiovascular diseases, such as heart attack and stroke, result from smoking. The Heart Foundation states that CVD is a major cause of death in Australia, with 43,477 deaths attributed to CVD in 2017. The rate of diagnosis of cardiovascular diseases is increasing over time due to rising burden of cardiac diseases and the need to control mortality rate by early diagnosis, and treatment for CVD with the help of cardiac monitoring devices. The other factors, such as technological advancements and the demand for home-based, point of care and remote monitoring cardiac systems are also anticipated to drive the market in the forecast period.
Asia-Pacific Cardiac Monitoring Industry Segmentation
Continuous cardiac monitoring is an important tool in the clinical assessment of patients with a variety of conditions. It allows the detection of changes in heart rate and rhythm and is essential in the detection of life-threatening arrhythmia's.
Device Type | |
ECG Monitor | |
Event Recorder | |
Implantable Cardiac Loop Recorder | |
Pacemaker | |
Defibrillator | |
Cardiac Resynchronization Therapy (CRT) Devices | |
Smart Wearable | |
Other Device Types |
End User | |
Hospitals and Clinics | |
Home Care Settings | |
Ambulatory Surgical Centers |
Geography | ||||||||
|
Asia-Pacific Cardiac Monitoring Market Size Summary
The Asia-Pacific cardiac monitoring market is poised for significant growth, driven by the increasing prevalence of cardiovascular diseases and a rapidly aging population susceptible to heart conditions. The market is characterized by the development and adoption of advanced cardiac monitoring devices that enhance diagnostic accuracy and reduce infection risks. These devices play a crucial role in early diagnosis and treatment, helping to mitigate the mortality rates associated with cardiovascular diseases. The demand for innovative solutions, such as home-based and remote monitoring systems, is further propelling market expansion. Key players in the industry, including Abbott Laboratories, Biotronik, and Medtronic PLC, are at the forefront of introducing technologically advanced products that cater to the evolving needs of healthcare providers and patients.
The market is segmented into various device types, including ECG monitors, event recorders, implantable cardiac loop recorders, pacemakers, defibrillators, CRT devices, and smart wearables. ECG devices, in particular, are gaining traction due to their ability to continuously monitor patients and detect issues early, thereby preventing costly emergency interventions. The integration of Bluetooth sensor technology and mobile applications is enhancing the functionality and appeal of these devices. As technological advancements continue to shape the landscape, the Asia-Pacific cardiac monitoring market is expected to experience robust growth, supported by ongoing innovations and the increasing demand for efficient and effective cardiac care solutions.
Asia-Pacific Cardiac Monitoring Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rising Burden of Cardiovascular Diseases
-
1.2.2 Demand for Home-based, Point of Care and Remote Patients Monitoring Cardiac Systems
-
1.2.3 Technological Advancements
-
-
1.3 Market Restraints
-
1.3.1 Risk of Infection Due to Implantable Monitoring Devices
-
1.3.2 Lack of Skilled Personnel
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 Device Type
-
2.1.1 ECG Monitor
-
2.1.2 Event Recorder
-
2.1.3 Implantable Cardiac Loop Recorder
-
2.1.4 Pacemaker
-
2.1.5 Defibrillator
-
2.1.6 Cardiac Resynchronization Therapy (CRT) Devices
-
2.1.7 Smart Wearable
-
2.1.8 Other Device Types
-
-
2.2 End User
-
2.2.1 Hospitals and Clinics
-
2.2.2 Home Care Settings
-
2.2.3 Ambulatory Surgical Centers
-
-
2.3 Geography
-
2.3.1 Asia-Pacific
-
2.3.1.1 China
-
2.3.1.2 Japan
-
2.3.1.3 India
-
2.3.1.4 Australia
-
2.3.1.5 South Korea
-
2.3.1.6 Rest of Asia-Pacific
-
-
-
Asia-Pacific Cardiac Monitoring Market Size FAQs
How big is the Asia-Pacific Cardiac Monitoring Market?
The Asia-Pacific Cardiac Monitoring Market size is expected to reach USD 4.65 billion in 2024 and grow at a CAGR of 5.77% to reach USD 6.16 billion by 2029.
What is the current Asia-Pacific Cardiac Monitoring Market size?
In 2024, the Asia-Pacific Cardiac Monitoring Market size is expected to reach USD 4.65 billion.